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The SH2 domain from the tyrosine kinase Fyn in complex with a
phosphotyrosyl peptide reveals insights into domain stability 
and binding specificity
Terrence D Mulhern1†, Graeme L Shaw1, Craig J Morton1, Anthony J Day2
and Iain D Campbell1*
Background: SH2 domains are found in a variety of signal transduction
proteins; they bind phosphotyrosine-containing sequences, allowing them to
both recognize target molecules and regulate intramolecular kinase activity. Fyn
is a member of the Src family of tyrosine kinases that are involved in signal
transduction by association with a number of membrane receptors. The kinase
activity of these signalling proteins is modulated by switching the binding mode
of their SH2 and SH3 domains from intramolecular to intermolecular. The
molecular basis of the signalling roles observed for different Src family
members is still not well understood; although structures have been determined
for the SH2 domains of other Src family molecules, this is the first structure of
the Fyn SH2 domain.
Results: The structure of the Fyn SH2 domain in complex with a
phosphotyrosyl peptide (EPQpYEEIPIYL) was determined by high resolution
NMR spectroscopy. The overall structure of the complex is analogous to that
of other SH2–peptide complexes. Noteworthy aspects of the structure are:
the BG loop, which contacts the bound peptide, contains a type-I′ turn; a
capping-box-like interaction is present at the N-terminal end of helix αA;
cis–trans isomerization of the ValβG1–ProβG2 peptide bond causes
conformational heterogeneity of residues near the N and C termini of the
domain.
Conclusions: Comparison of the Fyn SH2 domain structure with other
structures of SH2 domains highlights several interesting features. Conservation
of helix capping interactions among various SH2 domains is suggestive of a
role in protein stabilisation. The presence of a type-I´ turn in the BG loop, which
is dependent on the presence of a glycine residue at position BG3, is indicative
of a binding pocket, characteristic of the Src family, SykC and Abl, rather than a
binding groove found in PLC-γ1C, p85αN and Shc, for example.
Introduction
Human pp59fyn (Fyn) is a member of the Src family of cel-
lular non-receptor tyrosine kinases that, collectively, are
involved in the cytoplasmic signal transduction cascade for
a variety of membrane receptors (reviewed in [1]). These
molecules are of a modular nature, consisting of a unique
N-terminal sequence, three protein modules (the SH3,
SH2 and kinase domains) connected by linker regions and
a C-terminal tail (shown schematically in Figure 1a).
Recently determined structures of the inactive state of
essentially intact Src [2] and Hck [3] molecules have given
great insight into the processes involved in the regulation
of Src family kinase activity. Although some of the global
aspects of kinase regulation are now clear [4], the features
that give rise to the different biological roles of Src family
members have yet to be elucidated.
Fyn interacts with the T-cell receptor ζ chain–CD3
complex [5], integrins via the focal adhesion kinase
pp125FAK [6] and glycosyl phosphatidylinositol (GPI)
anchored receptors lacking cytoplasmic domains [7]. The
specificity of the Fyn SH2 domain for phosphotyrosine
(pY)-containing sequences is similar to that of other
members of the Src family; it binds, with highest affinity,
peptide ligands in which both of the residues immediately
C-terminal to the pY residue (the +1 and +2 positions) are
glutamate and the +3 residue is isoleucine [8].
A number of crystal and solution structures of Src family
SH2 domains have been determined (Src [2,9–12], Lck
[13–16], Blk [17] and Hck [3]). This is the first report of a
structure for the SH2 domain of Fyn, however. Structures
have also been determined of a variety of SH2 domains
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from molecules that are not members of the Src family
(e.g. p85αN [18]; PLC-γ1C [19]; Abl [20]; Grb2 [21]; ZAP-
70 [22]; SykC [23]; SypN [24]; and Shc [25]). Many of
these SH2 domains are notable in that they bind the
residues C-terminal to the pY residue in a groove, rather
than in a tight pocket as occurs for Src family members.
The relatively large number of different SH2 structures
available allows detailed comparisons to be made of subtle
structural similarities and differences. Indeed, although
some of the important structural determinants of peptide
binding have been elucidated [13], our comparison of the
Fyn SH2 with other SH2 domains has highlighted the crit-
ical role of residue GlyBG3 (the third residue of the BG
loop) in the formation of a tight hydrophobic pocket rather
than a binding groove.
Results
NMR spectroscopy data
The solution structure of the SH2 domain from human
p59fyn (residues 143–248) in complex with a pY-contain-
ing peptide EPQpYEEIPIYL, corresponding to residues
321–331 of hamster polyomavirus middle T antigen [26],
was determined by high-resolution NMR spectroscopy.
Structures were generated using dynamical simulated
annealing, employing 1608 experimentally derived
restraints, composed of 1505 NOE restraints, 39 dihedral
angle restraints and 32 hydrogen bonds (with two restraints
per hydrogen bond). NMR experiments were recorded
on unlabelled, 15N-labelled and 13C/15N-labelled protein
samples containing unlabelled peptide. Of the 1505 NOE
restraints used in the calculations, 368 were intraresidue,
414 were sequential, 213 were medium range (i to i + j,
j ≤ 4), 371 were long range (i to i+j, j ≥ 5) and 34 were inter-
molecular (SH2–peptide). In addition, there were 105 dis-
tance restraints that remained ambiguous, with unresolved
contributions from two or more groups or protons (five of
these restraints involved intermolecular interactions).
The sequence of the expressed clone, the location of sec-
ondary structure elements and a residue-by-residue break-
down of experimental restraints are shown in Figure 1.
Final structures (22) were selected on the basis of having
the lowest overall energy, and they had no NOE violations
> 0.3 Å and no dihedral angle violations > 5°. The Cα trace
for the minimised average coordinates are shown in Figure
2. Statistics for the entire family and the energy min-
imised average structure are shown in Table 1.
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Figure 1
Summary of the Fyn domain structure, SH2
sequence and experimental restraints. (a)
Schematic representation of the Fyn tyrosine
kinase. The locations of the SH3, SH2 and
kinase domains are shown along with the
myristate and palmitate moieties, the
autoregulatory PPII helix and phosphotyrosine.
(b) The sequence of the Fyn SH2 construct
used in this study with the position of the
secondary structure elements underlined. (c)
Graph of the residue-by-residue breakdown of
experimental restraints used in the structure
calculation. The phosphotyrosine containing
peptide precedes the SH2 domain with its
sequence shown below, where the pY is
underlined.
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Structure
Isotope-filtered experiments
The use of X-filtered experiments for differentiating
between protons attached to 13C or 15N and those
attached to unlabelled nuclei has been demonstrated in a
number of experiments [27–29]. The X-filtered NOESY
experiment [27] provides a convenient way of assigning
NOEs in complexes between labelled and unlabelled
species. X-filtered NOESY and TOCSY experiments
were used here to obtain the 1H chemical shift assign-
ments of the unlabelled peptide in the complex and to
identify NOEs from the unlabelled peptide to the
labelled protein; they were also useful in identifying
several slowly exchanging threonine hydroxyl protons
(Thr174 and Thr223) on the protein. The X-filtered
experiments were modified to include a double-pulse
field gradient spin echo (DPFGSE) at the end of the
pulse sequence to achieve water suppression [30]. In
addition, the 90x90±x pulses used in the X-filter were
replaced with the composite pulse 90±x180–x270x [31]. By
alternating the phase of the 90° pulse, the composite
pulse acts as either a 0° pulse or a 180° pulse on z-mag-
netisation. The larger band width of the composite pulse
makes the X-filter more effective when used to suppress
protons attached to 13C spins; similar improvements have
been observed by incorporating a hyperbolic secant pulse
into the X-filter [28].
Description of the solution structure
The SH2 domain of Fyn is similar to that of other Src
family members. It consists of a large triple-stranded
antiparallel β sheet (βB, βC and βD) flanked by two α
helices (αA and αB), with an additional short β strand (βA)
arranged parallel to the first strand of the large β sheet and
a small triple-stranded antiparallel β sheet (βD′, βE and
βF) involving the C-terminal end of the third strand of the
large β sheet (βD′). In other Src family SH2 structures, an
additional β strand (βG), corresponding to residues
Val244–Ser246 in Fyn, has been found; however, these
residues were not well-defined in the Fyn structure. A
superposition of the 22 final structures and a MOLSCRIPT
[32] representation of the energy minimised average coor-
dinates showing the secondary structure elements is pre-
sented in Figure 3.
Three cysteine residues in the native sequence in, and
close to, β-strand βG (CysBG5, CysBG6, of loop BG, and
CysβG3) were mutated to serine residues for this study to
eliminate the requirement for the sample to be maintained
under reducing conditions. Comparisons of 1H–15N-HSQC
NMR data for the wild-type sequence [33] with that of this
Cys → Ser mutant suggested that these mutations have a
minimal impact on the overall protein conformation. The
lack of a well-defined conformation for strand βG in the
structures of this Fyn mutant, however, could be due to
local unfolding as a result of the reduction in hydrophobic
contacts that would otherwise be expected for the cysteine
residues in the wild-type sequence. The Fyn construct
used in this study has six residues preceding βA and two
residues following the residues corresponding to βG. In
common with many other SH2 domains, the N and C
termini of the polypeptide chain are close together in
space, but despite the presence of several NOEs between
residues near the N and C termini, the first six residues
(Ser143–Glu148) and the last nine residues (Ser240–
His248) are not particularly well-defined with respect to
the protein as a whole.
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Figure 2
Stereoview of the Cα trace of the energy
minimised average coordinates. The Cα atom
of every 10th residue is labelled and the non-
hydrogen atoms of the peptide residues which
interact with the protein (pY, +1E, +2E and
+3I) are shown.
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Structure
Quality of the NMR structure
In the family of 22 final structures, 77.8% of the backbone
φ and ψ angles are well-defined with angular order para-
meters (AOPs; [34]) of ≥ 0.9 (94 φ angles and 88 ψ angles).
Superposition of the backbone N, Cα and C′ atoms of the
well-defined residues (having both φ and ψ well-defined)
on their mean coordinates gave a root mean squared devia-
tion (rmsd) of 0.57 ± 0.08 Å for their backbone N, Cα, C´
atoms and 0.98 ± 0.09 Å for heavy atoms. A superposition
of the backbone atoms of the peptide and protein residues
for which intermolecular NOEs were detected (pY, +1E,
+3I, ThrBC2, SerβC3, HisβD4–LysβD6, IleβE4, ThrEF1
and GlyBG3–SerBG5, where +1E and +3I refers to the
residues in the +1 and +3 positions immediately C-termi-
nal to pY) on their mean coordinates gave an rmsd of
0.36 ± 0.09 Å for the backbone atoms and 0.73 ± 0.16 Å for
their heavy atoms. Plots of the residue-by-residue AOPs
and rmsds are shown in Figure 4.
Using the Ramachandran regions defined by Morris et al.
[35], the angular averages for non-glycine/proline residues
(100 of the 117 residues in the complex) place 67 residues
in the most favoured regions (A, B and L), 30 in the addi-
tional allowed regions (a, b, l and p) and three in the gen-
erously allowed regions (~a, ~b, ~l and ~p). No angular
average values occur in the disallowed regions of the
Ramachandran plot.
Peptide-binding interaction
The peptide-binding interaction is of the classical two-
pronged-plug type [13], with the pY and +3I sidechains
inserted into two discrete binding pockets on either side
of the main β-sheet structure. The intervening peptide
between pY and +3I is in a largely extended conformation
and lies orthogonal to the β sheet. The pY sidechain sits in
a pocket, the sides of which are formed by residues
SerβB7, ThrBC2, SerβC3, HisβD4, TyrβD5 and LysβD6.
Intermolecular NOEs were observed between the pY
residue and ThrBC2, SerβC3, HisβD4, TyrβD5 and
LysβD6. The guanidinium group of ArgβB5 is located at
the bottom of the pocket and forms salt bridges with the
pY phosphate group in 64% of the final structures; this
interaction is well-formed in these structures, despite the
fact that no NOEs were detected between these two
residues. In the X-ray structures of Src SH2–peptide com-
plexes, ArgαA2 has also been implicated in a guanidino–
aromatic interaction with the pY ring, and in a salt-bridge
formation with the pY phosphate oxygens [9–10]. NMR
spectroscopic studies on the Src SH2–pYEEI complex,
however, did not reveal evidence for this interaction in
solution [12]. In the Fyn SH2 structures, the sidechain 
of ArgαA2 is poorly defined and makes no consistent
ArgαA2–pY interaction in the calculated structures,
however, ArgαA2 and the residues around it do show back-
bone NH chemical shift changes upon peptide binding.
The +3I sidechain sits in a pocket on the other side of the
main β sheet. At this pocket (composed of residues
TyrβD5, IleβE4, ThrEF1, GlyBG3 and LeuBG4) the
peptide has been described as being held between the
‘jaws’ formed by the EF and BG loops [13]. Intermolecular
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Table 1
Structural statistics for the 22 Fyn SH2–peptide complex
structures*.
Deviations from restraints <SA> (SA)r
Rmsd (Å) from (1505) 0.036 ± 0.001 
distance restraints
Rmsd (°) from dihedral 0.38 ± 0.13
angle restraints (39)
Deviations from covalent geometry <SA> (SA)r
bonds (Å) × 103 3.28 ± 0.08 3.21
angles (°) 0.565 ± 0.008 0.547
impropers (°) 0.420 ± 0.008 0.409
X-PLOR energies (kcal/mol)† <SA> (SA)r
Etot 356.4 ± 13.3 333.3
Ebond 20.91 ± 0.97 20.04
Eangle 169.62 ± 5.18 159.31
Eimpr 20.12 ± 0.84 18.67
Erepel 46.12 ± 4.45 42.79
EL–J –1062.0 ± 85.6 –1170.29
ENOE 99.24 ± 5.41 92.17
Ecdih 0.39 ± 0.22 0.28
Cartesian coordinate rmsds (Å) N, Ca, C¢ Heavy atoms
for <SA> versus (SA)
well defined‡ 0.57 ± 0.08 0.98 ± 0.09
all protein 0.96 ± 0.13 1.41 ± 0.13
all protein + peptide 1.23 ± 0.16 1.72 ± 0.15
binding site§ 0.36 ± 0.09 0.73 ± 0.16
*<SA> is the ensemble of 22 final simulated annealing structures, (SA)
is the mean coordinate set calculated after superposition of the
backbone N, Cα and C′ atoms of the well-defined SH2 residues and
(SA)r is the representative structure generated by restrained energy
minimisation of the mean coordinate set. †The van der Waals repulsion
term Erepel was calculated with a force constant of 4 kcal mol–1 Å–4
and the atomic radii set to 0.75 times those in the allhdg parameter
set. The distance restraint energy term ENOE and dihedral angle
restraint term Ecdih were calculated with force constants of
50 kcal mol–1 Å–2 and 200 kcal mol–1 rad–2, respectively. ‡The well-
defined residues (having both AOPφ and AOPψ ≥ 0.9) were residues
TyrβA2–GluαA6, GlnαA8–LeuαA10, ProAB5–GlyAB7,
IleβB4–ArgβC7, AspCD2–AsnDE2, TyrβE2–SerBG5, +1E and +2E.
Three other well-defined residues ValBG9, +4P and +6Y were
excluded from the superposition as they are locally well-defined, but
their positions in the protein and peptide C-terminal tails makes them
poorly defined with respect to the rest of the structure. §The binding-
site residues (SH2 and peptide residues which displayed
intermolecular NOEs) were ThrBC2, SerβC3, HisβD4–LysβD6,
IleβE4–ThrEF1, GlyBG3–SerBG5, pY, +1E and +3I.
NOEs were observed between the +3I residue and
TyrβD5, IleβE4, ThrEF1 GlyBG3, LeuBG4 and SerBG5.
Although intermolecular NOEs were observed between
the +1E residue and HisβD4 and TyrβD5, no intermolec-
ular NOEs were detected involving +2E.
Conformational heterogeneity
For nine residues, an alternate set of minor peaks were also
assigned. These residues were located near the N and C
termini, in βA (TrpβA1, TyrβA2 and PheβA3), the AB loop
(GlyAB1) and in αB (LeuαB2 and GlnαB3). The minor
sets of resonances were, on average, two thirds as intense as
the major form. The source of the multiple conformations
was identified as a cis–trans isomerization of the ValβG1–
ProβG2 peptide bond near the C terminus of the molecule.
In the major (trans) form, the N and C-terminal regions
show relatively few structurally significant NOEs and, as a
result, are disordered in the final structures. In the minor
(cis) form, however, NOEs could be detected between
SerβG3 and TyrβA2. It appears that the conformational het-
erogeneity is transmitted from ProβG2 via steric contacts
between the C-terminal and N-terminal tails to βA and the
AB loop. There is no spectral evidence for multiple confor-
mations, as such, for LeuαB2 and GlnαB3, but it appears
that they show two sets of peaks due to the different ring
current shielding, they receive from TrpβA1 in its two alter-
native positions. Interestingly, NMR data for the SH3–SH2
module pair under identical solution conditions (TDM,
unpublished results) indicate that this conformational het-
erogeneity is absent in the larger construct and that the
single conformation in the SH3–SH2 corresponds to the
more highly populated trans-isomer in the isolated SH2.
aB helix capping interaction
As mentioned previously, the hydroxyl group of ThrαB1 is
protected from solvent exchange. The hydroxyl hydrogen
is not hydrogen bonded itself, but is buried due to involve-
ment of its hydroxyl oxygen in a helix capping interaction,
reminiscent of the capping-box motif [36,37]. The capping
box generally involves a sequence motif of the form
S/T–X–X–E/Q, in which the serine or threonine is located
at the N-cap position of the helix and the glutamate or glu-
tamine is located at the N+3 position. A reciprocal hydro-
gen-bonding arrangement occurs between the N-cap and
N+3 residues, in which the sidechain of the N-cap forms a
hydrogen bond with the backbone NH of N+3 and the
sidechain of the N+3 residue forms a hydrogen bond with
the backbone NH of the N-cap. In the capping box, the
N-cap residue adopts a characteristic backbone conforma-
tion with φ = –94 ± 15° and ψ = 167 ± 5° [36]. As a result,
capping boxes also display characteristic deviations of the
Cα and Cβ chemical shifts from random coil values [38].
In Fyn SH2, although the 13C chemical shifts match the
expected pattern, the capping box hydrogen-bonding
arrangement is somewhat distorted, with a hydrogen
bond formed between the sidechain hydroxyl oxygen of
the N-cap (ThrαB1) and the backbone NH of the N+2
residue (GlnαB3) rather than the N+3 position (GlnαB4).
The backbone conformation of ThrαB1 reflects this dis-
tortion having φ = –143 ± 6° and ψ = 179 ± 6°. No recip-
rocating hydrogen bonds were detected between the
sidechains of either GlnαB3 or GlnαB4 with any back-
bone NH groups.
Discussion
Helix capping in SH2 domains
A hitherto unexplored aspect of SH2 structure is the pres-
ence of helix capping motifs on αA and αB. Inspection of
SH2 sequences (Figure 5) shows that many SH2 domains
contain putative capping box or capping box-like sequence
motifs on both αA and αB.
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Figure 3
NMR solution structures of the Fyn
SH2–peptide complex. (a) A superposition of
the 22 final structures showing the backbone
N, Cα and C′ atoms of the SH2 domain and
the backbone N, Cα and C′ atoms of peptide
pY (green) to +3I (red) residues as well as the
pY and +3I sidechains. (b) A schematic
representation of the energy minimised
average coordinates, showing the location of
the secondary structure elements (see text).
Colour scheme: β strands, yellow; α helices,
magenta; and loops, blue.This figure was
prepared using the programs MOLSCRIPT
[32] and Raster3D [62,63].
Helix αA in Fyn lacks the N-cap serine or threonine
required for a capping-box formation, however, many
other SH2 domains have the correct sequence motif, and
partly formed capping boxes can be found in Lck [13],
peptide-free Src [10] and peptide-bound Src [12] in
which the αA1 sidechain hydrogen bonds to the back-
bone NH of αA4, but the reciprocal interaction is
lacking. Helix αB of Fyn has a distorted capping box in
which the ThrαB1 sidechain hydrogen bonds to the
backbone NH of GlnαB3, rather than GlnαB4. This type
of distorted partial-capping box can also be found in
SykC [23]. The solution structure of the Src SH2–pYEEI
complex [12] contains a quite different distorted capping
box, in which the correct SerαB1–GluαB4 hydrogen
bond is present, but the reciprocal interaction is dis-
torted, such that the sidechain of GluαB4 hydrogen
bonds to the backbone NH of PheFB1, the residue pre-
ceding αB1. The peptide-free Src SH2 structure [10]
contains the GluαB4–PheFB1 hydrogen bond, but lacks
the αB1–αB4 hydrogen bond.
1318 Structure 1997, Vol 5 No 10
Figure 4
Backbone rmsd and angular order
parameters. The portions of the graphs
corresponding to the peptide are lightly
shaded, whereas those for the SH2 domain
are more heavily shaded. (a) Backbone rmsd
values. (b–d) Angular order parameters for φ,
ψ and χ1, respectively. The least well-defined
regions are the peptide and the protein N and
C termini along with the SH2 AB loop
(residues 165–171), CD loop (residues
192–198) and DE loop (residues 209–211).
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It is interesting that some SH2 modules exist without a
capping box, or with distorted or partially formed capping
boxes. It has been suggested that helix capping interac-
tions enhance protein stability [39] and delineate helix
termination points during folding [36]. The presence of
capping-box sequence motifs, but not completely formed
capping-box interactions, suggests that the stabilising
influences of the capping-box hydrogen bonds may act
early on in the folding process, but are not required for
protein stability when tertiary contacts increase as the
protein approaches the native fold.
BG-loop conformation
An alignment of SH2 sequences is shown in Figure 5.
Where the coordinates were available, the Ramachandran
region occupied by each non-glycine and non-proline
residue is also shown. The sequences and Ramachandran
alignments have been grouped according their peptide
ligand sequence preferences [8].
When analysing the peptide binding of Lck, Eck et al. [13]
highlighted the strict conservation of tyrosine at βD5 and
a characteristic Asp–Gly–Leu sequence for BG2–BG4 in
members of the Src family as well as some other SH2s,
suggestive of a shared +3 hydrophobic pocket conforma-
tion. They noted that the BG-loop conformation was con-
strained by a hydrogen bond between the sidechain of
TyrβD5 and the backbone NH of BG5. In a complex
between Src and the same peptide as studied in our work
presented here, Waksman et al. [10] noted that the Cα
atom of GlyBG3 makes close contact with the +3I
sidechain and that substitution of leucine for GlyBG3 and
a six-residue insertion in this region of the p85αN SH2
domain [18] resulted in selection for methionine at the +3
position over isoleucine.
Both the tyrosine residue at βD5 and the βD5–BG5 hydro-
gen bond are present in Fyn, however, Fyn does not have
the Asp–Gly–Leu sequence in the BG loop. Both Fyn and
Yrk have alanine, not aspartate at position BG2; the
Ramachandran alignment shows that in SH2s which display
type IA specificities (and SykC, which displays type IB
specificity) it is not necessarily the residue type at BG2, but
the presence of a positive φ angle that is conserved. An
analysis of these structures shows that residues BG1–BG4
form a type-I′ turn with the concomitant hydrogen bond
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Figure 5
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zap70N   FFY GSI SRAEAEEHLK LAGMADG LFLLRQC LR SLG GYVLSLVH  D   V  RFHHFPI ERQ LNG TYAI  AGG KAH C CPAELCEFYSRD PDGL      PCNLR KPC 
zap70C   WYH SSL TREEAERKLY SGAQTDG KFLLRPR KE  QG TYALSLIY  G   K  TVYHYLI SQD KAG KYCI  PEG TKF D TLWQLVEYLKLK ADGL      IYCLK EAC   
 
PLCg1C   WYH ASL TRAQAEHMLM RVP RDG AFLVRKR NE  PN SYAISFRA  E   G  KIKHCRV QQE GQ  TVML   GN SEF D SLVDLISYYEKH PLYR      KMKLR YPI
  GRB2   WFF GKI PRAKAEEMLS KQR HDG AFLIRES ES APG DFSLSVKF  G   N  DVQHFKV LRD GAG KYFL   WV VKF N SLNELVDYHRST SVSRN    QQIFLR DIE
 p85aN   WYW GDI SREEVNEKLR DT  ADG TFLVRDA STKMHG DYTLTLRK  G   G  NNKLIKI FHR  DG KYGF  SDP LTF N SVVELINHYRNE SLAQYN PKLDVKLL YPV    
  sypN   WFH PNI TGVEAENLLL TRG VDG SFLARPS KS NPG DFTLSVRR  N   G  AVTHIKI QNT GD  YYDL  YGG EKF A TLAELVQYYMEH HGQLKEKNGDVIELK YPL
   shc   WFH GKL SRREAEALL  Q   LNG DFLVRES TT TPG QYVLTGLQ  S   G  QPKHLLL VDP  EG VVRT   KD HRF E SVSHLISYHMDN HLPIIS AGSELCLQ QPV 
         βA  AA     αA        AB       βB     BC      βC       CD       βD   βD’ DE   βE    EF  βF FB     αB            BG    
   src X ABA -bB BAAAAAAAAb BaaB-B- BBBBBBB AA BB- BBBBBBBB BBAbD-B BBBBBBB BBB AA- -BBa  BAA BBB A BAAAAAAAAAAB Al-B      AbBBa BBB   
   fyn N aBA -bB -AAAAAAAAA AA-B-b- bBBBbBB AA bA- bbBbBBBB BBaaa-B bbbBBbB BBB AA- -BBA  BAA bBb A BAAAAAAAAAAB Al-b      AbbbB a-b
   lck X ABb AAB BAAAAAAAAA B--BbB- BBBBBBB AA BB- BBBBBBBB BBAAA-B BBBBBBB BBB BD- -BBA  B-A BBB - -AAAAAAAAAAb Al-B      ABBBa B-b
   blk N ABB bbB BAAAAAAAAA B-AbBb- BBBbBBB AA Ba- BbBBBBBB BBA A-B bbBBBBB BBB AA- -BBA  B-A BBB - BAAAAAAAAAaB - lBBBa B-D
   
  sykC N abB -ab aaAAAAAAAA A-DDAl- BBBBBBb BB  b- BBBBBBBa  a   -  bBBBBBB bba lA- BBBB  -A- bBB A BAAAAAAAAAAb Al-b      ABbBa B-A   
   abl N aBa --B BAAAAAaAb  Ab- bA- BBBBBBB ba B-- BBBBBBBb  a   -  BBBBBBB BBa aa- BBBA  baA bBB A BAAAAAAAAAab ba-B      abBba b-B
     
   
plcg1C N aBB AbB BAaAAAAAAA AB- lB- BBBBBBb ab  -b bbBBBBBB  a   -  BBBBBBB BBB -a  bBBA  -A  BBB A bAAAAAAAAAAB -abA      aBBDA b-B
  GRB2 N ABa -lB -AAAAAAAAA ABA BB- BBBBBBB AA b-- BBBBBBBB  -   a  BBBBBBB BBA -a- BBBa   aa BBB A BAAAAAAAAAAB BABAa    BbBBBB BB
 p85aN N ABA -lb BAAAAAaAAA bB  bb- BbbBBBB bAAaa- abBBBBBb  -   -  BBBBBBB BBa  a- bB-a  aB- laa b BAAAaAAAAAAa bbAAAB -aBBBBba b-B
  Nsyp X ABB -AB B-AAAAAAAA AA- BB- BBBBB-B AA b-- BBBBBBBB  L   -  BBBBBBB BBA -Ab bBbb  l-- BBB A BAAAAAAAAAAb A-ABBBDa-BBBBbA B-B
   shc X ABa -bB BAAAAAAAB  a   Bb- BBbBBBb aA b-- bBBBB-Bb  l   -  B-BbBBB Bb-  b- abBb   Aa BBb A bAAAAAAAAAAA lB-BBB L-BBBBBa B-b
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Structure
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(b)
Sequence and Ramachandran alignments for SH2 domains. (a)
Sequence alignments of SH2 domains. The four N-terminal residues
on αA and αB are highlighted in yellow. Where a putative capping box
sequence motif (S/TXXE/Q) is present, the residues are shown in red.
Residues BG1–BG4, in those SH2 domains that exhibit type-I binding,
are highlighted in blue. (b) Where structures were available, the
Ramachandran region occupied by each residue is shown. For
convenience, the allowed regions, a, b, l and p, include the generously
allowed regions, ~a, ~b, ~l and ~p. The type of structure is indicated
by X (X-ray crystal) or N (NMR solution). For NMR solution structures,
the entire ensemble was analysed using an in-house program
(ANGORDER) to yield all the dihedral angles, their respective angular
averages and AOPs, the Ramachandran region occupied by each
residue in the ensemble and the Ramachandran region occupied by
the angular average for each residue. The less well-defined residues
(those having an AOP for φ or ψ < 0.8) are shown in magenta.
between the NH of LeuBG4 and the backbone carbonyl of
BG1. A strict requirement for the formation of a type-I′ turn
is a glycine residue at the third position in the turn [40].
Figure 6 shows a superposition of BG-loop residues,
residue TyrβD5 and, where present, the bound peptide
for Fyn, Lck [13], Src [10], Blk [17] and SykC [23]. All of
the molecules have very similar BG-loop conformations. It
therefore would appear that another important determi-
nant of the formation of a hydrophobic +3 pocket, and
thus type-I binding (and specifically type-1A binding), is a
glycine residue at position BG3, such that a hydrogen
bond can form between BG1 and BG4 as part of a type-I′
turn. This hydrogen bond, in conjunction with the
βD5–BG5 hydrogen bond, constrains the conformation
and positioning of the BG loop with respect to the other
peptide binding site residues. An interesting exception to
this is the Abl SH2 domain. It has a glycine residue at BG3
and displays type-1B specificity, selecting for proline at
the +3 position. Although the solution structure of the Abl
SH2 domain does not show a type-I′ turn in the BG loop,
the polypeptide chain follows a very similar path to the
other examples above and it does have a hydrophobic +3
pocket, rather than a groove. The availability of more
structures of SH2 domains that display variants of type-1B
binding should be able to resolve why these differences
exist and further extend our ability to predict the binding
preferences of new SH2 domains.
Biological implications
SH2 domains are found in a variety of signal transduc-
tion proteins. The ability of SH2 domains to bind
polypeptide sequences containing phosphorylated tyro-
sine residues allows them to be involved in both the
recognition of target molecules and the regulation of
intramolecular kinase activity.
We have determined the NMR solution structure of the
SH2 domain from the Src family tyrosine kinase Fyn in
complex with a phosphotyrosine-containing peptide. The
structure and binding properties of the Fyn SH2 domain
are similar to those of other members of the Src family.
In recent years, structures have been determined of a
wide range of SH2 domains and this large number of
SH2 domain structures provides a useful pool of struc-
tural data from which sequence diversity can be
analysed in terms of subtle structural differences. We
have highlighted two aspects of SH2 domain structure,
namedly, helix capping interactions and binding-loop
conformation. Many SH2 domains appear to have
capping-box sequence motifs, but not completely formed
capping-box interactions; it is therefore apparent that
the role of helix capping interactions in SH2 domain
folding and stability warrants further investigation. Our
work also suggests that a significant marker of SH2
specificity is the presence, or otherwise, of a glycine
residue at position three in the BG loop (BG3). In SH2
domains which display type-I two-pronged-plug peptide
binding, the conformation of the BG loop, and thus the
positioning of a critical leucine residue that makes major
contacts with the hydrophobic ‘prong’ of the binding
sequence, is determined by the presence of a tyrosine
residue at position five in β-sheet D and a glycine at
BG3. Intimate knowledge of the determinants of SH2
domain stability and substrate specificity will facilitate
the design of specific SH2 ligands or SH2 containing
molecules for therapeutic purposes.
Materials and methods
Expression vector construction
The pGEX-2T plasmid encoding residues 82–252 of human Fyn
(nucleotides 823–1323 [41]) was a kind gift of CE Rudd (Dana-Farber
Cancer Institute, Harvard Medical School, Boston, MA). This vector
provided the template for amplification of DNA encoding amino acids
82–248 using Tli polymerase (Promega). The 5′ primer (5′-AATTAAT-
CATATGACAGGAGTGACACTCTTTGTGGC) introduced a NdeI site
and an ATG start codon (underlined) in frame with codon 82 of Fyn.
The 3′ primer (5′-AAGAATTCTTATTTGTGAGAGGGAACTACTAG-
GCGGGAGGAGAGACC) mutated Cys239, Cys240 and Cys246 to
serine residues, and introduced a TAA stop codon followed by an
EcoRI restriction site. The PCR product was digested with NdeI and
EcoRI, subcloned into the corresponding sites in pRK172 [42], and
confirmed as having no amplification errors. This vector (denoted fynIII-
6), which expresses the SH3–linker–SH2 polypeptide, was subse-
quently used to generate an SH2 construct (expressing residues
143–248 of Fyn) by deletion mutagenesis. The mutagenesis was per-
formed using the Transformer site-directed mutagenesis kit (Clontech),
according to the manufacturer’s instructions. In this procedure, the
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Figure 6
Comparison of BG-loop conformation, and relative peptide and TyrβD5
positions. Fyn (orange), Blk (red) [17], Lck (yellow) [13], Src (green)
[10], and SykC (cyan) [23]. The backbone N, Cα and C′ atoms are
shown for residues BG1–BG4, TyrβD5 and peptide residues pY to
+3I. Also displayed are the non-hydrogen sidechain atoms of TyrβD5,
pY and +3I, the N and HN atoms of BG5, the HN of BG4 and the
carbonyl O of BG1. The BG1–BG4 and TyrβD5–BG5 hydrogen
bonds are shown as dashed lines for Src. Residue BG5 is not shown
for Blk as the orientation of this residue is poorly defined in the solution
structures. Structures were superimposed over the backbone atoms of
the displayed residues.
selection primer (5′-GGTTTCCCCCTAGGAATAATTTTGTT) changed
a unique XbaI site in the pRK172 cloning cassette into an AvrII site,
and the mutation primer (5′-GAAGGAGATATACATATGTCTATC-
CAGGCAGAAG) deleted the sequence encoding amino acids
82–142 leaving the ATG start site (underlined) in frame with the codon
for Ser143. The mutant plasmid, designated Fyn4a-2, was transformed
into the E. coli expression strain BL21(DE3)pLysS [43].
Protein expression and purification
Unlabelled protein was produced from cell culture in Luria broth. The
production of 15N- and 15N/13C-labelled protein was achieved by cul-
turing the E. coli cells in vitamin supplemented M8 minimal media with
15NH4Cl as the sole nitrogen source, or 15NH4Cl and 13C6-glucose as
the sole nitrogen and carbon sources, respectively. Gene expression
was induced by the addition of 0.1 mM isopropyl-D-thiogalactopyra-
noside to the culture. Purification of both labelled and unlabelled
protein was carried out as follows. Cells were harvested by centrifuga-
tion at 4°C, 4 h after the induction of expression, then stored at –20°C.
For processing, the cells were resuspended in TTBS (50 mM Tris-HCl,
pH 8.5, 150 mM NaCl with 0.1% (v/v) Triton X-100) at a ratio of 10 ml
TTBS per gram of cells. To prevent protein degradation by E. coli pro-
tease enzymes, phenylmethyl-sulfonylflouride was added to a final con-
centration of 2 mM. The cell suspension was sonicated on ice
(6 ± 30s) to effect lysis of the cells. Cell debris was removed by cen-
trifugation (30 min, 20,000 g) at 4°C and the pellet discarded. The
supernatant was passed through a column of phosphotyrosine agarose
beads (Sigma). After extensive washing of the resin with TTBS fol-
lowed by TBS (TTBS without Triton X-100), the bound Fyn SH2 was
eluted from the column by a wash of TBS containing additional NaCl to
1.15 M. Analysis of the eluted material by SDS-PAGE and mass spec-
trometry (for unlabelled protein, 12281.9 Da compared with a theoreti-
cal value of 12278.7 Da) indicated that no contaminating proteins
were present in the eluate, the affinity purification step produced clean
Fyn SH2 that did not require further purification.
Peptide production
The peptide EPQpYEEIPIYL, residues 321–331 from the hamster
middle T antigen, which has been shown to bind to Fyn with high affin-
ity was prepared by solid-state synthesis and purified by reverse-phase
HPLC as described previously [33].
NMR sample preparation
Initial NMR samples containing only SH2 displayed broad line widths
[33] and were found to precipitate rapidly at 30°C and over time at
4°C (results not shown). By comparison, SH2 samples containing the
peptide showed reduced line widths and were indefinitely stable in
solution. Hence, all subsequent NMR samples contained peptide and
were prepared according to the following protocol. The SH2 eluted
from the pY–agarose was concentrated by ultrafiltration over YM3
membranes (Amicon) to a protein concentration of approximately
50 mM and then buffer exchanged into 10 mM phosphate, 0.02% NaN3,
pH 6.0. Into this solution, a 1.5 × molar excess of peptide was added
and the solution concentrated using centricon concentrators (YM3) to
a protein concentration of ~0.5–1 mM. At this point, further phosphate
buffer was added and the sample reconcentrated, iteratively, in order to
remove excess unbound peptide. Finally, D2O was added to 10% and
the pH adjusted to 6.0 by small additions of 0.1 M NaOD and DCl. The
protein concentrations in the resulting NMR samples were in the range
0.8–1.5 mM (measured spectrophotometrically at 280 nm using
ε = 11777 M–1cm–1 which was determined from amino acid analysis).
Chemical shift assignments
Spectra were recorded at 20°C at 500, 600 or 750 MHz on home-
built spectrometers. Sequential assignment of the backbone N, NH
and CαH resonances was achieved using 3D-NOESY-1H–15N-HSQC
and 3D-TOCSY-1H–15N-HSQC [44,45] data recorded at 750 MHz on
the 15N-labelled sample. Poor TOCSY transfer in the protein
sidechains resulted in only partial sidechain 1H assignments being
obtained from these data. More complete sidechain 1H assignments
(> 90%) were made from analysis of 13C/15N-labelled protein by 3D-
CBCA(CO)NH [46], 2D-1H–13C-HSQC [47] and 3D-HCCH-TOCSY
[48] spectra recorded at 500 MHz supplemented by 2D-1H-NOESY
[49], 2D-1H-TOCSY [50] and 2D-1H-DQF-COSY [51] data recorded
at 600 and 750 MHz. During the assignment process, non-degenerate
prochiral groups were arbitrarily named such that the lower branch
number was assigned to downfield resonance. 1H assignments for the
bound peptide were made from 2D X-filtered TOCSY and NOESY
data (described below) recorded at 500 MHz using the 13C/15N-
labelled sample. NH and sidechain amide assignments for the free
SH2 were made from 2D-1H–15N-HSQC [47] data recorded on a
sample containing 0.5 mM peptide and 1.5 mM SH2.
X-filtered experiments
High power 1H, 15N, and 13C pulses were applied using field strengths
of 27.5 kHz, 5.2 kHz, and 14.7 kHz, respectively. The selective 1H
pulse used as part of the DPFGSE water suppression sequence was a
2.0 ms Gaussian 180° pulse [52]. During t1, the 1H–13C couplings
were refocused using a 0.5 ms hyperbolic secant 180° pulse [53]
applied with a maximum field strength of 12.5 kHz. The 1H, 15N, and
13C transmitters were positioned at 4.7 ppm, 117.5 ppm, and 40.0 ppm
respectively. During acquisition, decoupling was achieved using a
1.0 kHz WALTZ-16 modulated field [54] and a 2.5 kHz GARP modu-
lated field [55] for 15N and 13C, respectively. In the X-filtered NOESY
experiment, a mixing time of 150 ms was used. DIPSI-2 [56] was
applied using a field strength of 7.6 kHz for 22.8 ms in the X-filtered
TOCSY experiment. For the X-filtered NOESY, a total of 160 and 1024
(complex) points were acquired in t1 and t2, respectively, using spectral
widths of 8000 Hz in both dimensions; 128 transients were recorded
for each FID. For the X-filtered TOCSY, a total of 320 (complex) and
1024 (complex) points were acquired in t1 and t2, respectively, using
spectral widths of 8000 Hz in both dimensions; 64 transients were
recorded for each FID. Prior to Fourier transformation, a mild Lorentz–
Gauss transformation was applied in t2 and a cosine bell window func-
tion was applied in t1.
Experimental restraints
NOEs were categorised as strong, medium and weak, and they were
given distance restraint upper bounds of 2.7, 3.5 and 5.0 Å, respec-
tively, based on relative NOE intensities for cross-peaks in residues in
well-defined secondary structure elements for which estimation of
actual distances was straight forward. The restraint list was based pri-
marily on NOEs observed in the 3D-1H–15N-HSQC-NOESY and 2D-
1H-NOESY spectra, both recorded at 750 MHz.
The values of 3JNα coupling constants were measured from the 2D-
1H–15N-HMQC-J [57] spectrum recorded at 600 MHz on the 15N-
labelled sample. For values of 3JNα < 5 Hz, φ was restrained to
–60 ± 30°; for values of 5 Hz < 3JNα < 5.5 Hz, φ was restrained to
–60 ± 40°; and for values of 3JNα > 8 Hz, φ was restrained to
–120 ± 40°.
Relative rates of backbone NH exchange were estimated from a series
of 2D-1H–15N-HSQC spectra recorded at 600 MHz on a sample
lyophilised from 90% 1H2O/10% D2O then redissolved in 100% D2O.
Hydrogen bond distance restraints were imposed for slowly exchang-
ing NH groups for which a single hydrogen bond acceptor was identi-
fied in > 60% of structures in preliminary rounds of structure
calculation. The distance restraints used were 1.5–2.3 Å between the
hydrogen bond donor and acceptor, and 2.3–3.3 Å between the hydro-
gen bond donor antecedent and the acceptor.
Structure calculations
Structures were generated in X-PLOR [58] using a dynamical simu-
lated annealing protocol based on that of Nilges and co-workers [59],
which includes the use of floating stereospecific assignment [60] and
ambiguous distance restraints [61]. During preliminary rounds of struc-
ture calculations, the energy cut-off for acceptance was set so that the
best 20% of structures were retained for analysis of hydrogen bonds
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and resolution of spectral ambiguity. For the final structures, a family of
200 initial structures were generated from templates with randomised
backbone φ and ψ angles by 19.5 ps of dynamics at 2000K followed
by annealing to 100K over 10.5 ps. These structures were then sub-
jected to a second round of the high temperature dynamics and simu-
lated annealing, and then were further refined by a final round of
simulated annealing where structures were cooled from 2000K to
100K over 30 ps. The 22 sets of coordinates with the lowest overall
energy were selected as the final structures. The use of floating stere-
ospecific assignments identified 3 glycine α-methylene groups (33%),
14 β-methylene groups (32%), 3 γ-methylene groups (37%), 4 leucine
methyl pairs (40%) and 1 valine methyl pair (25%) that adopted a
single orientation consistent with the NOE data. The values in paren-
theses indicate what proportion of the nondegenerate methylene and
methyl pairs this represents in each case.
Accession numbers
The coordinates for the family of NMR structures and the energy min-
imised average have been deposited with the Brookhaven Protein
Databank and have accession codes 1AOT and 1AOU, respectively.
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